Derval O'Carroll
Compliance Officer presso INFLARX N.V.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Derval O'Carroll is currently the SVP, Head-Global Regulatory Affairs & Compliance at InflaRx NV.
Previously, she worked as the Senior Director-Regulatory Affairs at Travere Therapeutics, Inc. from 2015 to 2017.
She also held the position of Head-Regulatory Affairs at Amryt Pharma Holdings Ltd.
and Amryt Pharma Plc.
Ms. O'Carroll completed her graduate studies and earned an MBA from University College Dublin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
INFLARX N.V.
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Derval O'Carroll
Società | Posizione | Inizio |
---|---|---|
INFLARX N.V. | Compliance Officer | 01/01/2022 |
Precedenti posizioni note di Derval O'Carroll
Società | Posizione | Fine |
---|---|---|
TRAVERE THERAPEUTICS, INC. | General Counsel | 01/12/2017 |
AMRYT PHARMA PLC | General Counsel | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | General Counsel | - |
Formazione di Derval O'Carroll
University College Dublin | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
INFLARX N.V. | Health Technology |
Aziende private | 2 |
---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Derval O'Carroll